Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Diltiazem hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diltiazem hydrochloride and what is the scope of diltiazem hydrochloride freedom to operate?

Diltiazem hydrochloride
is the generic ingredient in eleven branded drugs marketed by Actavis Labs Fl Inc, Valeant Pharms North, Valeant Intl, Hospira, Mylan, Athenex Inc, Sun Pharma Global, Sandoz, Biovail Labs Intl, West-ward Pharms Int, Biovail, Apotex, Intl Medication, Hikma Farmaceutica, Apothecon, Actavis Elizabeth, Nesher Pharms, Teva Pharms, Ivax Sub Teva Pharms, Mylan Labs Ltd, Teva, Par Pharm, Akorn Inc, Allergan Sales Llc, Chartwell Molecules, Teva Pharms Usa, and Apotex Inc, and is included in forty-five NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Diltiazem hydrochloride has twenty patent family members in eleven countries.

There are twenty-six drug master file entries for diltiazem hydrochloride. Forty-five suppliers are listed for this compound.

Summary for Generic Name: diltiazem hydrochloride

Drug Master File Entries: see list26
Suppliers / Packagers: see list45
Bulk Api Vendors: see list50
Clinical Trials: see list1,010
Patent Applications: see list3,355
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diltiazem hydrochloride at DailyMed

Pharmacology for Ingredient: diltiazem hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Intl
diltiazem hydrochloride
TABLET, EXTENDED RELEASE;ORAL021392-006Feb 6, 2003ABRXYesYes7,108,866► SubscribeY ► Subscribe
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL076151-002May 20, 2004DISCNNoNo► Subscribe► Subscribe
Mylan Labs Ltd
diltiazem hydrochloride
INJECTABLE;INJECTION075375-001Sep 30, 1999DISCNNoNo► Subscribe► Subscribe
Teva Pharms
diltiazem hydrochloride
TABLET;ORAL074067-002Nov 5, 1992DISCNNoNo► Subscribe► Subscribe
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019471-003Jan 23, 1989DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus